Abstract
Circular RNAs (circRNAs) are an endogenous RNAs with a covalently closed cyclic structure. They have emerged recently as key regulators in the development and progression of human cancers. However, the clinical values of most circRNAs in gastric cancer (GC) are unknown. Hsa_circ_0065149, one of the dysregulated circRNAs in gastric carcinogenesis detected by circRNA microarray, was chose as a targeted circRNA in this study. We firstly enlarged sample size and identified the level changes of hsa_circ_0065149 among four stages of gastric tumorigenesis from healthy gastric mucosa, gastritis, intestinal metaplasia to GC. Then, the potential relationship between hsa_circ_0065149 expression levels and GC patients’ clinicopathological factors was investigated. Moreover, the clinical significance of hsa_circ_0065149 in plasma exosomes and gastric juice were explored. Receiver operating characteristic (ROC) curve and Kaplan-Meier survival curve were constructed to evaluate diagnostic and prognostic values. Finally, bioinformatics analysis was performed to excavate the potential functions of hsa_circ_0065149. Hsa_circ_0065149 expression was only significantly down-regulated in gastric cancer, not changed among healthy gastric mucosa and gastritis intestinal metaplasia. Low hsa_circ_0065149 expression levels in GC tissues were significantly associated with tumor diameter (P = 0.034) and perineural invasion (P = 0.037). GC patients with low hsa_circ_0065149 levels had a much longer overall survival than those in high group (P = 0.020). More important, hsa_circ_0065149 levels were significantly decreased in plasma exosomes of early GC patients. As a screening biomarker for early GC, hsa_circ_0065149 in plasma exosomes has higher sensitivity and specificity than traditional clinical biomarkers. Bioinformatics analysis suggest that the abnormal expression of hsa_circ_0065149 may play an important role during gastric carcinogenesis. Those results indicate that hsa_circ_0065149 in exosmoes is an indicator for early GC screening and prognosis prediction.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(4):7–30
Tian M, Chen R, Li T, Xiao B (2018) Reduced expression of circRNA hsa_circ_0003159 in gastric cancer and its clinical significance. J Clin Lab Anal 32(3):e22281
Wang J, Qu J, Li Z, Che X, Liu J, Teng Y, Jin B, Zhao M, Liu Y, Qu X (2018) Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer. J Clin Lab Anal 32(3):e22185
Xie Y, Shao Y, Sun W, Ye G, Zhang X, Xiao B, Guo J (2018) Downregulated expression of hsa_circ_0074362 in gastric cancer and its potential diagnostic values. Biomark Med 12(1):11–20
Salzman J (2016) Circular RNA expression: its potential regulation and function. Trends Genet 32(5):309–316
Zhang Y, Liang W, Zhang P, Chen J, Qian H, Zhang X, Xu W (2017) Circular RNAs: emerging cancer biomarkers and targets. J Exp Clin Cancer Res 36(1):152
Fu L, Jiang Z, Li T, Hu Y, Guo J (2018) Circular RNAs in hepatocellular carcinoma: functions and implications. Can Med 7:3101–3109. https://doi.org/10.1002/cam4.1574
Qu S, Liu Z, Yang X, Zhou J, Yu H, Zhang R, Li H (2018) The emerging functions and roles of circular RNAs in cancer. Cancer Lett 414:301–309
Kristensen LS, Hansen TB, Venø MT, Kjems J (2018) Circular RNAs in cancer: opportunities and challenges in the field. Oncogene 37(5):555–565
Shao Y, Li J, Lu R, Li T, Yang Y, Xiao B, Guo J (2017) Global circular RNA expression profile of human gastric cancer and its clinical significance. Can Med 6(6):1173–1180
Yu Z, Wei L, Peng Z, Chen J, Qian H, Zhang X, Xu W (2017) Circular RNAs: emerging cancer biomarkers and targets. J Exp Clin Cancer Res 36(1):152
Li H, Hao X, Wang H, Liu Z, He Y, Pu M, Zhang H, Yu H, Duan J, Qu S (2016) Circular RNA expression profile of pancreatic ductal adenocarcinoma revealed by microarray. Cell Physiol Biochem 40(6):1334–1344
Fu L, Yao T, Chen Q, Mo X, Hu Y, Guo J (2017) Screening differential circular rna expression profiles reveals hsa_circ_0004018 is associated with hepatocellular carcinoma. Oncotarget 8(35):58405–58416
Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T, Hatzigeorgiou AG (2015) DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 43(1):460–466
Liu J, Liu T, Wang X, He A (2017) Circles reshaping the RNA world: from waste to treasure. Mol Cancer 16(1):58
Zhang Y, Liu H, Li W, Yu J, Li J, Shen Z, Ye G, Qi X, Li G (2017) CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630. Aging 9(6):1585–1594
Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W, Yu R, Xiao B, Guo J (2018) Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med 96(1):85–96
Wang H, Huang C, Zheng C, Li P, Xie W, Wang J, Lin J, Lu J (2012) Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach. World J Gastroenterol 18(38):5470–5475
Deng J, You Q, Gao Y, Yu Q, Zhao P, Zheng Y, Fang W, Xu N, Teng L (2014) Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis. PLoS One 9(2):e88907
Lu J, Huang C, Zheng C, Li P, Xie J, Wang J, Lin J (2013) Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. Surg Oncol 22(3):167–171
Lu J, Huang C, Zheng C, Li P, Xie J, Wang J, Lin J, Chen Q, Cao L, Lin M (2014) Prognostic value of tumor size in patients with remnant gastric cancer: is the seventh UICC stage sufficient for predicting prognosis? PLoS One 9(12):e115776
Zhou Z, Xu G, Zhang W, Zhao H, Wu Y (2014) Reevaluating significance of perineural invasion in gastric cancer based on double immunohistochemical staining. Arch Pathol Lab Med 138(2):229–234
Fan F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H (2017) Diagnostic and prognostic value of CEA, CA19–9, AFP and CA125 for early gastric cancer. BMC Cancer 17(1):737
Whiteside TL (2015) The potential of tumor-derived exosomes for noninvasive cancer monitoring. Expert Rev Mol Diagn 15(10):1293–1310
Greening DW, Gopal SK, Xu R, Simpson RJ, Chen W (2015) Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol 40:72–81
Fernando MR, Jiang C, Krzyzanowski GD, Ryan WL (2017) New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One 12(8):e0183915
Cui L, Zhang X, Ye G, Zheng T, Song H, Deng H, Xiao B, Xia T, Yu X, Le Y, Guo J (2013) Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 119(9):1618–1626
Rong D, Sun H, Li Z, Liu S, Dong C, Fu K, Tang W, Cao H (2017) An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget 8(42):73271–73281
Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng J, Hou J, Lin L, Cai J (2018) Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med 16(1):216
Funding
This study was supported by grants from the National Natural Science Foundation of China (No. 81702367), the Medical and Health Research Project of Zhejiang Province (No. 2017KY598, No. 2018KY159), the Scientific Innovation Team Project of Ningbo (No. 2017C110019), and the K. C. Wong Magna Fund in Ningbo University.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing Interests
The authors disclose no conflicts.
Ethical Approval
This study was approved by the Human Research Ethics Committee of Ningbo University School of Medicine.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 1518 kb)
Rights and permissions
About this article
Cite this article
Shao, Y., Tao, X., Lu, R. et al. Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction. Pathol. Oncol. Res. 26, 1475–1482 (2020). https://doi.org/10.1007/s12253-019-00716-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-019-00716-y